FDA Clears Novo's Kid-Friendly Insulin Pen

The NovoPen Echo®

| Aug 22, 2013

The U.S. Food and Drug Administration has granted 510(k) clearance for the NovoPen Echo®, the first insulin injection device on the market to combine half-unit dosing with a memory function to help patients manage their diabetes.

Manufacturer Novo Nordisk says the pen represents a significant milestone in insulin delivery, especially for children with diabetes and their caregivers. "It can offer caregivers increased confidence that their children are managing their diabetes appropriately away from home by allowing them to see the amount and time passed since their last dose," said Camille Lee, senior vice president, Diabetes Marketing, at Novo Nordisk.

Lee said half-unit dose increments allow for finer adjustments, which can be particularly important for children. In addition, different removable skins will be available for a customized look.

The pen, which Novo Nordisk plans to introduce to the U.S. market in 2014, will be available to patients for use with NovoLog® (insulin aspart [rDNA origin] injection) PenFill® cartridges.

Click Here To View Or Post Comments

Categories: FDA, Insulin Pen , Novo Nordisk, NovoPen Echo


Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Latest
Popular
Top Rated

Latest Insulin Pen Articles

Print | Email | Share | Comments (0)

You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Aug 22, 2013

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.